|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net (loss)/profit from continuing operations | |||
| Net profit from discontinued operations | |||
| Adjustments to reconcile net profit/(loss) to net cash used in operating activities: | |||
| Interest expense | |||
| Bad debt expenses | |||
| (Gain)/Loss on change of fair value of warrant liability | |||
| Changes in operating assets and liabilities (decrease)/increase in - continuing operations: | |||
| Other current assets | |||
| Loan receivables | |||
| Prepayment | |||
| Accrued expenses and other payables | |||
| Advances from customer | |||
| Net changes in operating assets and liabilities (decrease)/increase - discontinued operations | |||
| Net cash used in operating activities-continuing operations | |||
| Net cash used in operating activities-discontinued operations | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Disposal of subsidiaries, net of cash | |||
| Net cash provided by investing activities-continuing operations | |||
| Net cash provided by investing activities-discontinued operations | |||
| Net Cash provided by investing activities | |||
| Cash flows from financing activities: | |||
| Repayment to a short-term borrowing from a third party, net | |||
| Proceeds from a private placement | |||
| Proceeds from issuance of convertible note | |||
| Payment for offering costs | |||
| Net cash provided by/(used in) financing activities-continuing operations | |||
| Net cash provided by/(used in) financing activities | |||
| Net change in cash and cash equivalents, and restricted cash from continuing operations | |||
| Net change in cash and cash equivalents, and restricted cash from discontinued operations | |||
| Net change in cash and cash equivalents, and restricted cash | |||
| Cash and cash equivalents, and restricted cash beginning balance from continuing operations | |||
| Cash and cash equivalents, and restricted cash beginning balance from discontinued operations | |||
| Cash and cash equivalents, and restricted cash beginning balance | |||
| Cash and cash equivalents, and restricted cash ending balance from continuing operations | |||
| Total cash, cash equivalents, and restricted cash | |||
| Cash and cash equivalents, and restricted cash ending balance | |||
| Supplemental cash flows information: | |||
| Cash paid for tax | |||
| Cash received from interest-continuing operations | |||
| Warrants Exercised Cashless (in Shares) | |||
| March 1, 2024 | |||
| February 13, 2024 | |||
| June 17, 2024 | |||
| July 9, 2024 | |||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||
| Cash and cash equivalents-continuing operations | |||
| Restricted cash-continuing operations | |||
| Total cash and cash equivalents -continuing operations |
Loading...